Subpopulations of extracellular vesicles and their therapeutic potential

Molecular Aspects of Medicine

Volumn 60, Issue , 2018, Pages 1-14

  Lässer, Cecilia ^a   Jang, Su Chul ^a,b   Lötvall, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Translational Imaging Pathology   (United States)

Author keywords

Exosomes; Microparticles; Microvesicles

Indexed keywords

CURCUMIN; DNA; DOXORUBICIN; MICRORNA; PACLITAXEL; RNA; SMALL INTERFERING RNA; DRUG CARRIER; NUCLEIC ACID; PROTEIN;

ACUTE KIDNEY FAILURE; ALLERGIC ENCEPHALOMYELITIS; CANCER INHIBITION; CELL DENSITY; CELL MEMBRANE; CELL SUBPOPULATION; DRUG TARGETING; ELECTROPORATION; EXOSOME; GENE SILENCING; HEART INJURY; HUMAN; IMMUNOMODULATION; LIVER FIBROSIS; LIVER INJURY; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ORGANELLE BIOGENESIS; PANCREAS CANCER; PNEUMONIA; REVIEW; RNA INTERFERENCE; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ANIMAL; METABOLISM; PROCEDURES; THERAPY;

ANIMALS; DRUG CARRIERS; EXTRACELLULAR VESICLES; HUMANS; NUCLEIC ACIDS; PROTEINS; THERAPEUTICS;

EID: 85042069731     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2018.02.002     Document Type: Review

References (139)

1. Aalberts, M., van Dissel-Emiliani, F.M., van Adrichem, N.P., van Wijnen, M., Wauben, M.H., Stout, T.A., Stoorvogel, W., Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol. Reprod., 86(3), 2012, 82.
2. Admyre, C., Johansson, S.M., Qazi, K.R., Filen, J.J., Lahesmaa, R., Norman, M., Neve, E.P., Scheynius, A., Gabrielsson, S., Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179:3 (2007), 1969–1978.
3. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29:4 (2011), 341–345.
4. Arraud, N., Linares, R., Tan, S., Gounou, C., Pasquet, J.M., Mornet, S., Brisson, A.R., Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemostasis: JTH 12:5 (2014), 614–627.
5. Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., Zimmermann, P., David, G., Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14:7 (2012), 677–685.
6. Balaj, L., Lessard, R., Dai, L., Cho, Y.J., Pomeroy, S.L., Breakefield, X.O., Skog, J., Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun., 2, 2011, 180.
7. Besse, B., Charrier, M., Lapierre, V., Dansin, E., Lantz, O., Planchard, D., Le Chevalier, T., Livartoski, A., Barlesi, F., Laplanche, A., Ploix, S., Vimond, N., Peguillet, I., Thery, C., Lacroix, L., Zoernig, I., Dhodapkar, K., Dhodapkar, M., Viaud, S., Soria, J.C., Reiners, K.S., Pogge von Strandmann, E., Vely, F., Rusakiewicz, S., Eggermont, A., Pitt, J.M., Zitvogel, L., Chaput, N., Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. OncoImmunology, 5(4), 2016, e1071008.
8. Biggiogera, M., Bottone, M.G., Pellicciari, C., Nuclear RNA is extruded from apoptotic cells. J. Histochem. Cytochem.: Off. J. Histochem. Soc. 46:9 (1998), 999–1005.
9. Bobrie, A., Colombo, M., Krumeich, S., Raposo, G., Théry, C., Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J. Extracell. Vesicles, 1, 2012.
10. Booth, A.M., Fang, Y., Fallon, J.K., Yang, J.M., Hildreth, J.E., Gould, S.J., Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol. 172:6 (2006), 923–935.
11. Bronshtein, T., Toledano, N., Danino, D., Pollack, S., Machluf, M., Cell derived liposomes expressing CCR5 as a new targeted drug-delivery system for HIV infected cells. J. Contr. Release: Off. J. Control. Release Soc. 151:2 (2011), 139–148.
12. Brouwers, J.F., Aalberts, M., Jansen, J.W., van Niel, G., Wauben, M.H., Stout, T.A., Helms, J.B., Stoorvogel, W., Distinct lipid compositions of two types of human prostasomes. Proteomics 13:10–11 (2013), 1660–1666.
13. Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., Morando, L., Busca, A., Falda, M., Bussolati, B., Tetta, C., Camussi, G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20:5 (2009), 1053–1067.
14. Cai, J., Han, Y., Ren, H., Chen, C., He, D., Zhou, L., Eisner, G.M., Asico, L.D., Jose, P.A., Zeng, C., Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J. Mol. Cell Biol. 5:4 (2013), 227–238.
15. Casciola-Rosen, L.A., Anhalt, G., Rosen, A., Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:4 (1994), 1317–1330.
16. Chargaff, E., West, R., The biological significance of the thromboplastic protein of blood. J. Biol. Chem. 166:1 (1946), 189–197.
17. Collino, F., Pomatto, M., Bruno, S., Lindoso, R.S., Tapparo, M., Sicheng, W., Quesenberry, P., Camussi, G., Exosome and microvesicle-enriched fractions isolated from mesenchymal stem cells by gradient separation showed different molecular signatures and functions on renal tubular epithelial cells. Stem Cell Rev. 13:2 (2017), 226–243.
18. Colombo, M., Moita, C., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L.F., Thery, C., Raposo, G., Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell Sci. 126:Pt 24 (2013), 5553–5565.
19. Colombo, M., Raposo, G., Thery, C., Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30 (2014), 255–289.
20. Crescitelli, R., Lässer, C., Szabo, T.G., Kittel, A., Eldh, M., Dianzani, I., Buzás, E.I., Lötvall, J., Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J. Extracell. Vesicles, 2, 2013.
21. Cronqvist, T., Salje, K., Familari, M., Guller, S., Schneider, H., Gardiner, C., Sargent, I.L., Redman, C.W., Morgelin, M., Akerstrom, B., Gram, M., Hansson, S.R., Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS One, 9(2), 2014, e90020.
22. Cruz, F.F., Borg, Z.D., Goodwin, M., Sokocevic, D., Wagner, D.E., Coffey, A., Antunes, M., Robinson, K.L., Mitsialis, S.A., Kourembanas, S., Thane, K., Hoffman, A.M., McKenna, D.H., Rocco, P.R., Weiss, D.J., Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates Aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice. Stem Cells Translat. Med. 4:11 (2015), 1302–1316.
23. Cvjetkovic, A., Lötvall, J., Lässer, C., The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J. Extracell. Vesicles, 3, 2014.
24. Cvjetkovic, A., Jang, S.C., Konecna, B., Hoog, J.L., Sihlbom, C., Lasser, C., Lotvall, J., Detailed analysis of protein topology of extracellular vesicles-evidence of unconventional membrane protein orientation. Sci. Rep., 6, 2016, 36338.
25. Cvjetkovic, A., Crescitelli, R., Lässer, C., Zabeo, D., Widlund, P., Nyström, T., Höög, J.L., Lötvall, J., Extracellular vesicles in motion. Matters, 3(6), 2017.
26. Davidson, B.L., McCray, P.B. Jr., Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 12:5 (2011), 329–340.
27. Delcayre, A., Estelles, A., Sperinde, J., Roulon, T., Paz, P., Aguilar, B., Villanueva, J., Khine, S., Le Pecq, J.B., Exosome Display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol. Dis. 35:2 (2005), 158–168.
28. Didiot, M.C., Hall, L.M., Coles, A.H., Haraszti, R.A., Godinho, B.M., Chase, K., Sapp, E., Ly, S., Alterman, J.F., Hassler, M.R., Echeverria, D., Raj, L., Morrissey, D.V., DiFiglia, M., Aronin, N., Khvorova, A., Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol. Ther.: J. Am. Soc. Gene Ther. 24:10 (2016), 1836–1847.
29. Freed, E.O., Viral late domains. J. Virol. 76:10 (2002), 4679–4687.
30. Gatti, S., Bruno, S., Deregibus, M.C., Sordi, A., Cantaluppi, V., Tetta, C., Camussi, G., Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant.: Off. Publ. Europ. Dial. Transplant Assoc.Europ. Renal Assoc. 26:5 (2011), 1474–1483.
31. Gho, Y.S., Lee, C., Emergent properties of extracellular vesicles: a holistic approach to decode the complexity of intercellular communication networks. Mol. Biosyst. 13:7 (2017), 1291–1296.
32. Goh, W.J., Lee, C.K., Zou, S., Woon, E.C., Czarny, B., Pastorin, G., Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy. Int. J. Nanomed. 12 (2017), 2759–2767.
33. Gould, S.J., Raposo, G., As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles, 2, 2013.
34. Gross, J.C., Chaudhary, V., Bartscherer, K., Boutros, M., Active Wnt proteins are secreted on exosomes. Nat. Cell Biol. 14:10 (2012), 1036–1045.
35. Guescini, M., Genedani, S., Stocchi, V., Agnati, L.F., Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J. Neural. Transm. 117:1 (2010), 1–4.
36. Gupta, S., Knowlton, A.A., HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. American journal of physiology. Heart Circulat. Physiol. 292:6 (2007), H3052–H3056.
37. Gyorgy, B., Szabo, T.G., Pasztoi, M., Pal, Z., Misjak, P., Aradi, B., Laszlo, V., Pallinger, E., Pap, E., Kittel, A., Nagy, G., Falus, A., Buzas, E.I., Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci.: CMLS 68:16 (2011), 2667–2688.
38. Gyorgy, B., Hung, M.E., Breakefield, X.O., Leonard, J.N., Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu. Rev. Pharmacol. Toxicol. 55 (2015), 439–464.
39. Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., Rizzolio, F., Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine 11:18 (2016), 2431–2441.
40. Hao, L., Zou, Z., Tian, H., Zhang, Y., Zhou, H., Liu, L., Stem cell-based therapies for ischemic stroke. BioMed Res. Int., 2014, 2014, 468748.
41. Harris, J.M., Chess, R.B., Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2:3 (2003), 214–221.
42. Höög, J.L., Lötvall, J., Diversity of extracellular vesicles in human ejaculates revealed by cryo-electron microscopy. J. Extracell. Vesicles, 4, 2015, 28680.
43. Hoshino, D., Kirkbride, K.C., Costello, K., Clark, E.S., Sinha, S., Grega-Larson, N., Tyska, M.J., Weaver, A.M., Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 5:5 (2013), 1159–1168.
44. Hsu, C., Morohashi, Y., Yoshimura, S., Manrique-Hoyos, N., Jung, S., Lauterbach, M.A., Bakhti, M., Gronborg, M., Mobius, W., Rhee, J., Barr, F.A., Simons, M., Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 189:2 (2010), 223–232.
45. Hugle, T., Daikeler, T., Stem cell transplantation for autoimmune diseases. Haematologica 95:2 (2010), 185–188.
46. Huotari, J., Helenius, A., Endosome maturation. EMBO J. 30:17 (2011), 3481–3500.
47. Jackson, C.E., Scruggs, B.S., Schaffer, J.E., Hanson, P.I., Effects of inhibiting VPS4 support a general role for ESCRTs in extracellular vesicle biogenesis. Biophys. J. 113:6 (2017), 1342–1352.
48. Jang, S.C., Kim, O.Y., Yoon, C.M., Choi, D.S., Roh, T.Y., Park, J., Nilsson, J., Lotvall, J., Kim, Y.K., Gho, Y.S., Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7:9 (2013), 7698–7710.
49. Jang, S.C., Crescitelli, R., Cvjetkovic, A., Belgrano, V., Olofsson Bagge, R., Höög, L.J., Sundfeldt, K., Ochiya, T., Kalluri, R., Lötvall, J., A subgroup of mitochondrial extracellular vesicles discovered in human melanoma tissues are detectable in patient blood. 2017 Prepublication at BioRxiv).
50. Jeppesen, D.K., Hvam, M.L., Primdahl-Bengtson, B., Boysen, A.T., Whitehead, B., Dyrskjot, L., Orntoft, T.F., Howard, K.A., Ostenfeld, M.S., Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J. Extracell. Vesicles, 3, 2014, 25011.
51. Jo, W., Jeong, D., Kim, J., Cho, S., Jang, S.C., Han, C., Kang, J.Y., Gho, Y.S., Park, J., Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. Lab a Chip 14:7 (2014), 1261–1269.
52. Jo, W., Kim, J., Yoon, J., Jeong, D., Cho, S., Jeong, H., Yoon, Y.J., Kim, S.C., Gho, Y.S., Park, J., Large-scale generation of cell-derived nanovesicles. Nanoscale 6:20 (2014), 12056–12064.
53. Kalra, H., Drummen, G.P., Mathivanan, S., Focus on extracellular vesicles: introducing the next small big thing. Int. J. Mol. Sci., 17(2), 2016, 170.
54. Kamerkar, S., LeBleu, V.S., Sugimoto, H., Yang, S., Ruivo, C.F., Melo, S.A., Lee, J.J., Kalluri, R., Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546:7659 (2017), 498–503.
55. Karlsson, M., Lundin, S., Dahlgren, U., Kahu, H., Pettersson, I., Telemo, E., “Tolerosomes” are produced by intestinal epithelial cells. Eur. J. Immunol. 31:10 (2001), 2892–2900.
56. Kim, H.J., Kim, A., Miyata, K., Kataoka, K., Recent progress in development of siRNA delivery vehicles for cancer therapy. Adv. Drug Deliv. Rev. 104 (2016), 61–77.
57. Kim, M.S., Haney, M.J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N.L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., Hingtgen, S.D., Kabanov, A.V., Batrakova, E.V., Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed. Nanotechnol. Biol. Med. 12:3 (2016), 655–664.
58. Kim, O.Y., Lee, J., Gho, Y.S., Extracellular vesicle mimetics: novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines. Semin. Cell Dev. Biol. 67 (2017), 74–82.
59. Kim, Y.S., Kim, J.Y., Cho, R., Shin, D.M., Lee, S.W., Oh, Y.M., Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway. Exp. Mol. Med., 49(1), 2017, e284.
60. Kooijmans, S.A., Stremersch, S., Braeckmans, K., de Smedt, S.C., Hendrix, A., Wood, M.J., Schiffelers, R.M., Raemdonck, K., Vader, P., Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J. Contr. Release: Off. J. Control. Release Soc. 172:1 (2013), 229–238.
61. Kooijmans, S.A.A., Fliervoet, L.A.L., van der Meel, R., Fens, M., Heijnen, H.F.G., van Bergen En Henegouwen, P.M.P., Vader, P., Schiffelers, R.M., PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J. Contr. Release: Off. J. Control. Release Soc. 224 (2016), 77–85.
62. Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J.P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., Thery, C., Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl. Acad. Sci. U. S. A. 113:8 (2016), E968–E977.
63. Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S., Choo, A., Chen, T.S., Salto-Tellez, M., Timmers, L., Lee, C.N., El Oakley, R.M., Pasterkamp, G., de Kleijn, D.P., Lim, S.K., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4:3 (2010), 214–222.
64. Lakhal, S., Wood, M.J., Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays: News Rev. Mole. Cell. Develop. Biol. 33:10 (2011), 737–741.
65. Lässer, C., Shelke, G.V., Yeri, A., Kim, D.K., Crescitelli, R., Raimondo, S., Sjostrand, M., Gho, Y.S., Van Keuren Jensen, K., Lotvall, J., Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 14:1 (2017), 58–72.
66. Lazaro-Ibanez, E., Sanz-Garcia, A., Visakorpi, T., Escobedo-Lucea, C., Siljander, P., Ayuso-Sacido, A., Yliperttula, M., Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate 74:14 (2014), 1379–1390.
67. Lazaro-Ibanez, E., Lunavat, T.R., Jang, S.C., Escobedo-Lucea, C., Oliver-De La Cruz, J., Siljander, P., Lotvall, J., Yliperttula, M., Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines. BMC Canc., 17(1), 2017, 92.
68. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Remberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., Ringden, O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:9624 (2008), 1579–1586.
69. Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., Wang, M., Zhou, Y., Zhu, W., Li, W., Xu, W., Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cell. Dev. 22:6 (2013), 845–854.
70. Liu, H., Yu, X., Li, K., Klejnot, J., Yang, H., Lisiero, D., Lin, C., Photoexcited CRY2 interacts with CIB1 to regulate transcription and floral initiation in Arabidopsis. Science 322:5907 (2008), 1535–1539.
71. Lunavat, T.R., Cheng, L., Kim, D.K., Bhadury, J., Jang, S.C., Lasser, C., Sharples, R.A., Lopez, M.D., Nilsson, J., Gho, Y.S., Hill, A.F., Lotvall, J., Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells - evidence of unique microRNA cargos. RNA Biol. 12:8 (2015), 810–823.
72. Lunavat, T.R., Jang, S.C., Nilsson, L., Park, H.T., Repiska, G., Lasser, C., Nilsson, J.A., Gho, Y.S., Lotvall, J., RNAi delivery by exosome-mimetic nanovesicles - implications for targeting c-Myc in cancer. Biomaterials 102 (2016), 231–238.
73. Marzesco, A.M., Janich, P., Wilsch-Brauninger, M., Dubreuil, V., Langenfeld, K., Corbeil, D., Huttner, W.B., Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell Sci. 118:Pt 13 (2005), 2849–2858.
74. Mathivanan, S., Ji, H., Simpson, R.J., Exosomes: extracellular organelles important in intercellular communication. J. Proteom. 73:10 (2010), 1907–1920.
75. Morishita, M., Takahashi, Y., Matsumoto, A., Nishikawa, M., Takakura, Y., Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials 111 (2016), 55–65.
76. Mulcahy, L.A., Pink, R.C., Carter, D.R., Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles, 3, 2014.
77. Nabhan, J.F., Hu, R., Oh, R.S., Cohen, S.N., Lu, Q., Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc. Natl. Acad. Sci. U. S. A. 109:11 (2012), 4146–4151.
78. Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., Niidome, Y., PEG-modified gold nanorods with a stealth character for in vivo applications. J. Contr. Rel.: Off. J. Control. Rel. Soc. 114:3 (2006), 343–347.
79. Nolte-'t Hoen, E.N., Buermans, H.P., Waasdorp, M., Stoorvogel, W., Wauben, M.H., t Hoen, P.A., Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 40:18 (2012), 9272–9285.
80. O'Loughlin, A.J., Mager, I., de Jong, O.G., Varela, M.A., Schiffelers, R.M., El Andaloussi, S., Wood, M.J.A., Vader, P., Functional delivery of lipid-conjugated siRNA by extracellular vesicles. Mol. Ther.: J. Am. Soc. Gene Ther. 25:7 (2017), 1580–1587.
81. Oh, K., Kim, S.R., Kim, D.K., Seo, M.W., Lee, C., Lee, H.M., Oh, J.E., Choi, E.Y., Lee, D.S., Gho, Y.S., Park, K.S., In vivo differentiation of therapeutic insulin-producing cells from bone marrow cells via extracellular vesicle-mimetic nanovesicles. ACS Nano 9:12 (2015), 11718–11727.
82. Ohno, S., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., Gotoh, N., Kuroda, M., Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther.: J. Am. Soc. Gene Ther. 21:1 (2013), 185–191.
83. Ostrowski, M., Carmo, N.B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., Moita, C.F., Schauer, K., Hume, A.N., Freitas, R.P., Goud, B., Benaroch, P., Hacohen, N., Fukuda, M., Desnos, C., Seabra, M.C., Darchen, F., Amigorena, S., Moita, L.F., Thery, C., Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12:1 (2010), 19–30 sup pp. 11–13.
84. Palma, J., Yaddanapudi, S.C., Pigati, L., Havens, M.A., Jeong, S., Weiner, G.A., Weimer, K.M., Stern, B., Hastings, M.L., Duelli, D.M., MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res. 40:18 (2012), 9125–9138.
85. Pascucci, L., Cocce, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Vigano, L., Locatelli, A., Sisto, F., Doglia, S.M., Parati, E., Bernardo, M.E., Muraca, M., Alessandri, G., Bondiolotti, G., Pessina, A., Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J. Contr. Rel.: Off. J. Control. Release Soc. 192 (2014), 262–270.
86. Pegtel, D.M., Cosmopoulos, K., Thorley-Lawson, D.A., van Eijndhoven, M.A., Hopmans, E.S., Lindenberg, J.L., de Gruijl, T.D., Wurdinger, T., Middeldorp, J.M., Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 107:14 (2010), 6328–6333.
87. Poliakov, A., Spilman, M., Dokland, T., Amling, C.L., Mobley, J.A., Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 69:2 (2009), 159–167.
88. Poutsiaka, D.D., Schroder, E.W., Taylor, D.D., Levy, E.M., Black, P.H., Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages. J. Immunol. 134:1 (1985), 138–144.
89. Putz, U., Howitt, J., Lackovic, J., Foot, N., Kumar, S., Silke, J., Tan, S.S., Nedd4 family-interacting protein 1 (Ndfip1) is required for the exosomal secretion of Nedd4 family proteins. J. Biol. Chem. 283:47 (2008), 32621–32627.
90. Raposo, G., Stoorvogel, W., Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200:4 (2013), 373–383.
91. Raposo, G., Nijman, H.W., Stoorvogel, W., Liejendekker, R., Harding, C.V., Melief, C.J., Geuze, H.J., B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:3 (1996), 1161–1172.
92. Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., Ratajczak, M.Z., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:5 (2006), 847–856.
93. Reis, L.A., Borges, F.T., Simoes, M.J., Borges, A.A., Sinigaglia-Coimbra, R., Schor, N., Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One, 7(9), 2012, e44092.
94. Riazifar, M., Pone, E.J., Lotvall, J., Zhao, W., Stem cell extracellular vesicles: extended messages of regeneration. Annu. Rev. Pharmacol. Toxicol. 57 (2017), 125–154.
95. Ronquist, G., Brody, I., The prostasome: its secretion and function in man. Biochim. Biophys. Acta 822:2 (1985), 203–218.
96. Ronquist, K.G., Ronquist, G., Carlsson, L., Larsson, A., Human prostasomes contain chromosomal DNA. Prostate 69:7 (2009), 737–743.
97. Ronquist, G.K., Larsson, A., Ronquist, G., Isaksson, A., Hreinsson, J., Carlsson, L., Stavreus-Evers, A., Prostasomal DNA characterization and transfer into human sperm. Mol. Reprod. Dev. 78:7 (2011), 467–476.
98. Ronquist, K.G., Ek, B., Morrell, J., Stavreus-Evers, A., Strom Holst, B., Humblot, P., Ronquist, G., Larsson, A., Prostasomes from four different species are able to produce extracellular adenosine triphosphate (ATP). Biochim. Biophys. Acta 1830:10 (2013), 4604–4610.
99. Saari, H., Lazaro-Ibanez, E., Viitala, T., Vuorimaa-Laukkanen, E., Siljander, P., Yliperttula, M., Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J. Contr. Rel.: Off. J. Control. Release Soc. 220:Pt B (2015), 727–737.
100. Savina, A., Vidal, M., Colombo, M.I., The exosome pathway in K562 cells is regulated by Rab11. J. Cell Sci. 115:Pt 12 (2002), 2505–2515.
101. Shelke, G.V., Jang, S.C., Yin, Y., Lässer, C., Lötvall, J., Human mast cells release extracellular vesilce-associated DNA. Matters, 2016, 10.19185/matters.201602000034.
102. Sreekumar, P.G., Kannan, R., Kitamura, M., Spee, C., Barron, E., Ryan, S.J., Hinton, D.R., alphaB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS One, 5(10), 2010, e12578.
103. Srivastava, A., Amreddy, N., Babu, A., Panneerselvam, J., Mehta, M., Muralidharan, R., Chen, A., Zhao, Y.D., Razaq, M., Riedinger, N., Kim, H., Liu, S., Wu, S., Abdel-Mageed, A.B., Munshi, A., Ramesh, R., Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells. Sci. Rep., 6, 2016, 38541.
104. Sterzenbach, U., Putz, U., Low, L.H., Silke, J., Tan, S.S., Howitt, J., Engineered exosomes as vehicles for biologically active proteins. Mol. Ther.: J. Am. Soc. Gene Ther. 25:6 (2017), 1269–1278.
105. Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H.G., A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther.: J. Am. Soc. Gene Ther. 18:9 (2010), 1606–1614.
106. Sutaria, D.S., Jiang, J., Elgamal, O.A., Pomeroy, S.M., Badawi, M., Zhu, X., Pavlovicz, R., Azevedo-Pouly, A.C.P., Chalmers, J., Li, C., Phelps, M.A., Schmittgen, T.D., Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery. J. Extracell. Vesicles, 6(1), 2017, 1333882.
107. Tamai, K., Tanaka, N., Nakano, T., Kakazu, E., Kondo, Y., Inoue, J., Shiina, M., Fukushima, K., Hoshino, T., Sano, K., Ueno, Y., Shimosegawa, T., Sugamura, K., Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem. Biophys. Res. Commun. 399:3 (2010), 384–390.
108. Tan, C.Y., Lai, R.C., Wong, W., Dan, Y.Y., Lim, S.K., Ho, H.K., Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res. Ther., 5(3), 2014, 76.
109. Tauro, B.J., Greening, D.W., Mathias, R.A., Mathivanan, S., Ji, H., Simpson, R.J., Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol. Cell. Proteomics 12:3 (2013), 587–598.
110. Thery, C., Ostrowski, M., Segura, E., Membrane vesicles as conveyors of immune responses. Nature reviews. Immunology 9:8 (2009), 581–593.
111. Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G.J., Wei, J., Nie, G., A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:7 (2014), 2383–2390.
112. Toledano Furman, N.E., Lupu-Haber, Y., Bronshtein, T., Kaneti, L., Letko, N., Weinstein, E., Baruch, L., Machluf, M., Reconstructed stem cell nanoghosts: a natural tumor targeting platform. Nano Lett. 13:7 (2013), 3248–3255.
113. Tong, M., Kleffmann, T., Pradhan, S., Johansson, C.L., DeSousa, J., Stone, P.R., James, J.L., Chen, Q., Chamley, L.W., Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication. Hum. Reprod. 31:4 (2016), 687–699.
114. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brugger, B., Simons, M., Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:5867 (2008), 1244–1247.
115. Trams, E.G., Lauter, C.J., Salem, N. Jr., Heine, U., Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645:1 (1981), 63–70.
116. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9:6 (2007), 654–659.
117. van der Pol, E., Boing, A.N., Harrison, P., Sturk, A., Nieuwland, R., Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64:3 (2012), 676–705.
118. van Dommelen, S.M., Vader, P., Lakhal, S., Kooijmans, S.A., van Solinge, W.W., Wood, M.J., Schiffelers, R.M., Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Contr. Rel.: Off. J. Control. Release Soc. 161:2 (2012), 635–644.
119. Waldenstrom, A., Genneback, N., Hellman, U., Ronquist, G., Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One, 7(4), 2012, e34653.
120. Wang, L., Cong, X., Liu, G., Zhou, J., Bai, B., Li, Y., Bai, W., Li, M., Ji, H., Zhu, D., Wu, M., Liu, Y., Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cell. Dev. 22:24 (2013), 3192–3202.
121. Wang, Q., Zhuang, X., Mu, J., Deng, Z.B., Jiang, H., Zhang, L., Xiang, X., Wang, B., Yan, J., Miller, D., Zhang, H.G., Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat. Commun., 4, 2013, 1867.
122. Wiklander, O.P., Nordin, J.Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mager, I., Vader, P., Lee, Y., Sork, H., Seow, Y., Heldring, N., Alvarez-Erviti, L., Smith, C.I., Le Blanc, K., Macchiarini, P., Jungebluth, P., Wood, M.J., Andaloussi, S.E., Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles, 4, 2015, 26316.
123. Willms, E., Johansson, H.J., Mager, I., Lee, Y., Blomberg, K.E., Sadik, M., Alaarg, A., Smith, C.I., Lehtio, J., El Andaloussi, S., Wood, M.J., Vader, P., Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci. Rep., 6, 2016, 22519.
124. Yamout, B., Hourani, R., Salti, H., Barada, W., El-Hajj, T., Al-Kutoubi, A., Herlopian, A., Baz, E.K., Mahfouz, R., Khalil-Hamdan, R., Kreidieh, N.M., El-Sabban, M., Bazarbachi, A., Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J. Neuroimmunol. 227:1–2 (2010), 185–189.
125. Yang, Z., Xie, J., Zhu, J., Kang, C., Chiang, C., Wang, X., Kuang, T., Chen, F., Chen, Z., Zhang, A., Yu, B., Lee, R.J., Teng, L., Lee, L.J., Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation. J. Contr. Rel.: Off. J. Control. Rel. Soc. 243 (2016), 160–171.
126. Yang, Y., Hong, Y., Nam, G.H., Chung, J.H., Koh, E., Kim, I.S., Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv. Mater., 29(13), 2017.
127. Yim, N., Ryu, S.W., Choi, K., Lee, K.R., Lee, S., Choi, H., Kim, J., Shaker, M.R., Sun, W., Park, J.H., Kim, D., Heo, W.D., Choi, C., Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat. Commun., 7, 2016, 12277.
128. Yoon, J., Jo, W., Jeong, D., Kim, J., Jeong, H., Park, J., Generation of nanovesicles with sliced cellular membrane fragments for exogenous material delivery. Biomaterials 59 (2015), 12–20.
129. Yuan, Z., Kolluri, K.K., Gowers, K.H., Janes, S.M., TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy. J. Extracell. Vesicles, 6(1), 2017, 1265291.
130. Zabeo, D., Cvjetkovic, A., Lasser, C., Schorb, M., Lotvall, J., Hoog, J.L., Exosomes purified from a single cell type have diverse morphology. J. Extracell. Vesicles, 6(1), 2017, 1329476.
131. Zhang, Y., Peng, L., Mumper, R.J., Huang, L., Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials 34:33 (2013), 8459–8468.
132. Zhao, C., Busch, D.J., Vershel, C.P., Stachowiak, J.C., Multifunctional transmembrane protein ligands for cell-specific targeting of plasma membrane-derived vesicles. Small 12:28 (2016), 3837–3848.
133. Zheng, Y., Campbell, E.C., Lucocq, J., Riches, A., Powis, S.J., Monitoring the Rab27 associated exosome pathway using nanoparticle tracking analysis. Exp. Cell Res. 319:12 (2013), 1706–1713.
134. Zhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., Zhang, B., Wang, M., Mao, F., Yan, Y., Gao, S., Gu, H., Zhu, W., Qian, H., Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res. Ther., 4(2), 2013, 34.
135. Zhu, Y.G., Feng, X.M., Abbott, J., Fang, X.H., Hao, Q., Monsel, A., Qu, J.M., Matthay, M.A., Lee, J.W., Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cell. 32:1 (2014), 116–125.
136. Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R.C., Ju, S., Mu, J., Zhang, L., Steinman, L., Miller, D., Zhang, H.G., Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther.: J. Am. Soc. Gene Ther. 19:10 (2011), 1769–1779.
137. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:5 (1998), 594–600.
138. Zonneveld, M.I., Brisson, A.R., van Herwijnen, M.J., Tan, S., van de Lest, C.H., Redegeld, F.A., Garssen, J., Wauben, M.H., Nolte-'t Hoen, E.N., Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures. J. Extracell. Vesicles, 3, 2014.
139. Zorde Khvalevsky, E., Gabai, R., Rachmut, I.H., Horwitz, E., Brunschwig, Z., Orbach, A., Shemi, A., Golan, T., Domb, A.J., Yavin, E., Giladi, H., Rivkin, L., Simerzin, A., Eliakim, R., Khalaileh, A., Hubert, A., Lahav, M., Kopelman, Y., Goldin, E., Dancour, A., Hants, Y., Arbel-Alon, S., Abramovitch, R., Galun, E., Mutant KRAS is a druggable target for pancreatic cancer. Proc. Natl. Acad. Sci. U. S. A. 110:51 (2013), 20723–20728.